Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system.
Identifieur interne : 000B05 ( Ncbi/Merge ); précédent : 000B04; suivant : 000B06Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system.
Auteurs : Eduardo Mortola [Royaume-Uni] ; Polly RoySource :
- FEBS letters [ 0014-5793 ] ; 2004.
Descripteurs français
- KwdFr :
- Animaux, Assemblage viral, Baculoviridae (génétique), Cellules cultivées, Cytométrie en flux, Protéines recombinantes (métabolisme), Spodoptera, Technique d'immunofluorescence indirecte, Technique de Western, Virion (isolement et purification), Virion (métabolisme), Virion (ultrastructure), Virus du SRAS (métabolisme), Électrophorèse sur gel de polyacrylamide.
- MESH :
- génétique : Baculoviridae.
- isolement et purification : Virion.
- métabolisme : Protéines recombinantes, Virion, Virus du SRAS.
- ultrastructure : Animaux, Assemblage viral, Cellules cultivées, Cytométrie en flux, Spodoptera, Technique d'immunofluorescence indirecte, Technique de Western, Virion, Électrophorèse sur gel de polyacrylamide.
English descriptors
- KwdEn :
- Animals, Baculoviridae (genetics), Blotting, Western, Cells, Cultured, Electrophoresis, Polyacrylamide Gel, Flow Cytometry, Fluorescent Antibody Technique, Indirect, Recombinant Proteins (metabolism), SARS Virus (metabolism), Spodoptera, Virion (isolation & purification), Virion (metabolism), Virion (ultrastructure), Virus Assembly.
- MESH :
- chemical , metabolism : Recombinant Proteins.
- genetics : Baculoviridae.
- isolation & purification : Virion.
- metabolism : SARS Virus, Virion.
- ultrastructure : Virion.
- Animals, Blotting, Western, Cells, Cultured, Electrophoresis, Polyacrylamide Gel, Flow Cytometry, Fluorescent Antibody Technique, Indirect, Spodoptera, Virus Assembly.
Abstract
Virus-like particles (VLPs) produced by recombinant expression of the major viral structural proteins could be an attractive method for severe acute respiratory syndrome (SARS) control. In this study, using the baculovirus system, we generated recombinant viruses that expressed S, E, M and N structural proteins of SARS-CoV either individually or simultaneously. The expression level, size and authenticity of each recombinant SARS-CoV protein were determined. In addition, immunofluorescence and FACS analysis confirmed the cell surface expression of the S protein. Co-infections of insect cells with two recombinant viruses demonstrated that M and E could assemble readily to form smooth surfaced VLPs. On the other hand, simultaneous high level expression of S, E and M by a single recombinant virus allowed the very efficient assembly and release of VLPs. These data demonstrate that the VLPs are morphological mimics of virion particles. The high level expression of VLPs with correct S protein conformation by a single recombinant baculovirus offers a potential candidate vaccine for SARS.
DOI: 10.1016/j.febslet.2004.09.009
PubMed: 15474033
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002B25
- to stream PubMed, to step Curation: 002B25
- to stream PubMed, to step Checkpoint: 002D33
Links to Exploration step
pubmed:15474033Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system.</title>
<author><name sortKey="Mortola, Eduardo" sort="Mortola, Eduardo" uniqKey="Mortola E" first="Eduardo" last="Mortola">Eduardo Mortola</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT</wicri:regionArea>
<wicri:noRegion>London WC1E 7HT</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Roy, Polly" sort="Roy, Polly" uniqKey="Roy P" first="Polly" last="Roy">Polly Roy</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15474033</idno>
<idno type="pmid">15474033</idno>
<idno type="doi">10.1016/j.febslet.2004.09.009</idno>
<idno type="wicri:Area/PubMed/Corpus">002B25</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002B25</idno>
<idno type="wicri:Area/PubMed/Curation">002B25</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002B25</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002D33</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002D33</idno>
<idno type="wicri:Area/Ncbi/Merge">000B05</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system.</title>
<author><name sortKey="Mortola, Eduardo" sort="Mortola, Eduardo" uniqKey="Mortola E" first="Eduardo" last="Mortola">Eduardo Mortola</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT</wicri:regionArea>
<wicri:noRegion>London WC1E 7HT</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Roy, Polly" sort="Roy, Polly" uniqKey="Roy P" first="Polly" last="Roy">Polly Roy</name>
</author>
</analytic>
<series><title level="j">FEBS letters</title>
<idno type="ISSN">0014-5793</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Baculoviridae (genetics)</term>
<term>Blotting, Western</term>
<term>Cells, Cultured</term>
<term>Electrophoresis, Polyacrylamide Gel</term>
<term>Flow Cytometry</term>
<term>Fluorescent Antibody Technique, Indirect</term>
<term>Recombinant Proteins (metabolism)</term>
<term>SARS Virus (metabolism)</term>
<term>Spodoptera</term>
<term>Virion (isolation & purification)</term>
<term>Virion (metabolism)</term>
<term>Virion (ultrastructure)</term>
<term>Virus Assembly</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Assemblage viral</term>
<term>Baculoviridae (génétique)</term>
<term>Cellules cultivées</term>
<term>Cytométrie en flux</term>
<term>Protéines recombinantes (métabolisme)</term>
<term>Spodoptera</term>
<term>Technique d'immunofluorescence indirecte</term>
<term>Technique de Western</term>
<term>Virion (isolement et purification)</term>
<term>Virion (métabolisme)</term>
<term>Virion (ultrastructure)</term>
<term>Virus du SRAS (métabolisme)</term>
<term>Électrophorèse sur gel de polyacrylamide</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Recombinant Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Baculoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Baculoviridae</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Virion</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Virion</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>SARS Virus</term>
<term>Virion</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Protéines recombinantes</term>
<term>Virion</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="ultrastructure" xml:lang="en"><term>Virion</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Blotting, Western</term>
<term>Cells, Cultured</term>
<term>Electrophoresis, Polyacrylamide Gel</term>
<term>Flow Cytometry</term>
<term>Fluorescent Antibody Technique, Indirect</term>
<term>Spodoptera</term>
<term>Virus Assembly</term>
</keywords>
<keywords scheme="MESH" qualifier="ultrastructure" xml:lang="fr"><term>Animaux</term>
<term>Assemblage viral</term>
<term>Cellules cultivées</term>
<term>Cytométrie en flux</term>
<term>Spodoptera</term>
<term>Technique d'immunofluorescence indirecte</term>
<term>Technique de Western</term>
<term>Virion</term>
<term>Électrophorèse sur gel de polyacrylamide</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Virus-like particles (VLPs) produced by recombinant expression of the major viral structural proteins could be an attractive method for severe acute respiratory syndrome (SARS) control. In this study, using the baculovirus system, we generated recombinant viruses that expressed S, E, M and N structural proteins of SARS-CoV either individually or simultaneously. The expression level, size and authenticity of each recombinant SARS-CoV protein were determined. In addition, immunofluorescence and FACS analysis confirmed the cell surface expression of the S protein. Co-infections of insect cells with two recombinant viruses demonstrated that M and E could assemble readily to form smooth surfaced VLPs. On the other hand, simultaneous high level expression of S, E and M by a single recombinant virus allowed the very efficient assembly and release of VLPs. These data demonstrate that the VLPs are morphological mimics of virion particles. The high level expression of VLPs with correct S protein conformation by a single recombinant baculovirus offers a potential candidate vaccine for SARS.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15474033</PMID>
<DateCompleted><Year>2004</Year>
<Month>11</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>18</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0014-5793</ISSN>
<JournalIssue CitedMedium="Print"><Volume>576</Volume>
<Issue>1-2</Issue>
<PubDate><Year>2004</Year>
<Month>Oct</Month>
<Day>08</Day>
</PubDate>
</JournalIssue>
<Title>FEBS letters</Title>
<ISOAbbreviation>FEBS Lett.</ISOAbbreviation>
</Journal>
<ArticleTitle>Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system.</ArticleTitle>
<Pagination><MedlinePgn>174-8</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Virus-like particles (VLPs) produced by recombinant expression of the major viral structural proteins could be an attractive method for severe acute respiratory syndrome (SARS) control. In this study, using the baculovirus system, we generated recombinant viruses that expressed S, E, M and N structural proteins of SARS-CoV either individually or simultaneously. The expression level, size and authenticity of each recombinant SARS-CoV protein were determined. In addition, immunofluorescence and FACS analysis confirmed the cell surface expression of the S protein. Co-infections of insect cells with two recombinant viruses demonstrated that M and E could assemble readily to form smooth surfaced VLPs. On the other hand, simultaneous high level expression of S, E and M by a single recombinant virus allowed the very efficient assembly and release of VLPs. These data demonstrate that the VLPs are morphological mimics of virion particles. The high level expression of VLPs with correct S protein conformation by a single recombinant baculovirus offers a potential candidate vaccine for SARS.</AbstractText>
<CopyrightInformation>Copyright 2004 Federation of European Biochemical Societies</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mortola</LastName>
<ForeName>Eduardo</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Roy</LastName>
<ForeName>Polly</ForeName>
<Initials>P</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>FEBS Lett</MedlineTA>
<NlmUniqueID>0155157</NlmUniqueID>
<ISSNLinking>0014-5793</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016367" MajorTopicYN="N">Baculoviridae</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015153" MajorTopicYN="N">Blotting, Western</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004591" MajorTopicYN="N">Electrophoresis, Polyacrylamide Gel</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005434" MajorTopicYN="N">Flow Cytometry</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019084" MajorTopicYN="N">Fluorescent Antibody Technique, Indirect</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018411" MajorTopicYN="N">Spodoptera</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014771" MajorTopicYN="N">Virion</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
<QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019065" MajorTopicYN="Y">Virus Assembly</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2004</Year>
<Month>07</Month>
<Day>20</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2004</Year>
<Month>08</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2004</Year>
<Month>09</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2004</Year>
<Month>10</Month>
<Day>12</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2004</Year>
<Month>12</Month>
<Day>16</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2004</Year>
<Month>10</Month>
<Day>12</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15474033</ArticleId>
<ArticleId IdType="pii">S0014579304011238</ArticleId>
<ArticleId IdType="doi">10.1016/j.febslet.2004.09.009</ArticleId>
<ArticleId IdType="pmc">PMC7126153</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Nature. 1970 Aug 15;227(5259):680-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">5432063</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Acta Pharmacol Sin. 2003 Jun;24(6):489-96</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12791173</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>FEBS Lett. 2004 Oct 8;576(1-2):174-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15474033</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>EMBO J. 1996 Apr 15;15(8):2020-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8617249</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2004 Jun 11;318(4):833-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15147946</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4646-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1711206</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1997 Dec;71(12):9278-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9371586</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2000 Mar;74(5):2333-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10666264</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Vaccine. 1992;10(1):28-32</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1311487</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Acta Biochim Biophys Sin (Shanghai). 2004 Jan;36(1):37-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14732873</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 Nov 28;302(5650):1504-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14645828</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Feb 24;101(8):2536-41</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14983044</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proteomics. 2004 Feb;4(2):492-504</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14760722</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1998 Nov;72(11):8636-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9765403</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1986 May;151(1):41-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">3008432</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1991 May;65(5):2702-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1901917</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Microbiol Mol Biol Rev. 1998 Dec;62(4):1171-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9841669</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1996 Apr 1;218(1):52-60</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8615041</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 2001 Apr;75(8):3937-47</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11264382</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Clin Invest. 2003 Jun;111(11):1605-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12782660</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1999 Sep;73(9):7441-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">10438834</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 1990 Dec;179(2):874-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2238477</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Clin Microbiol. 1995 Jun;33(6):1452-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7650166</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1998 Aug;72(8):6838-50</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9658133</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Virology. 2002 Mar 1;294(1):222-36</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11886280</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1991 Jun;65(6):2946-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">1851866</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Gen Virol. 1995 Sep;76 ( Pt 9):2349-55</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7561776</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2100-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14762165</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1997 Dec;71(12):9427-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">9371603</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Virol. 1990 Dec;64(12):5695-700</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2173762</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
</list>
<tree><noCountry><name sortKey="Roy, Polly" sort="Roy, Polly" uniqKey="Roy P" first="Polly" last="Roy">Polly Roy</name>
</noCountry>
<country name="Royaume-Uni"><noRegion><name sortKey="Mortola, Eduardo" sort="Mortola, Eduardo" uniqKey="Mortola E" first="Eduardo" last="Mortola">Eduardo Mortola</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B05 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000B05 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:15474033 |texte= Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:15474033" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |